Clinical Toxicology

Top Research Topics at Clinical Toxicology?

The main research concerns discussed in Clinical Toxicology are Anesthesia, Pharmacology, Toxicity, Surgery and Internal medicine. The research on Anesthesia tackled can also make contributions to studies in the areas of Ingestion and Drug overdose. Issues in Internal medicine were discussed, taking into consideration concepts from other disciplines like Gastroenterology, Endocrinology and Cardiology.

• Anesthesia (24.79%)
• Pharmacology (13.26%)
• Toxicity (12.96%)

What are the most cited papers published in the journal?

• 2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report (681 citations)
• American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning (540 citations)
• Poisoning Severity Score. Grading of Acute Poisoning (494 citations)

Research areas of the most cited articles at Clinical Toxicology:

The published papers cover a variety of subjects, including Anesthesia, Toxicity, Surgery, Pharmacology and Internal medicine. The most cited publications explore issues in Anesthesia which can be linked to other research areas like Ingestion, Antidote, Emergency department and Drug overdose. The published papers about Pharmacokinetics and Drug are all disciplines of Pharmacology that connect with topics in Clinical toxicology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Surgery
• Pharmacology

The previous edition focused in particular on these issues:

Clinical Toxicology primarily tackles Emergency medicine, Pharmacology, Toxicity, Anesthesia and 2019-20 coronavirus outbreak. Emergency medicine research presented in Clinical Toxicology encompasses a variety of subjects, including Injury prevention, Emergency department and Incidence (epidemiology). It served as a forum through which researchers explored works on 2019-20 coronavirus outbreak in conjunction with disciplines such as Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Pandemic.

Clinical Toxicology served as a forum through which researchers explored different topics like Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Virology. Attendees of it participated in discussions that delve into both Pandemic and Hand sanitizer.

The most cited articles from the last journal are:

• Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution. (22 citations)
• Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. (9 citations)
• Blood concentrations of synthetic cannabinoids (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Clinical Toxicology (based on the number of publications) are:

• Robert S. Hoffman (132 papers) published 8 papers at the last edition, 2 more than at the previous edition,
• Nicholas A. Buckley (85 papers) published 8 papers at the last edition, 3 more than at the previous edition,
• Michael Eddleston (70 papers) published 9 papers at the last edition, 3 more than at the previous edition,
• Lewis S. Nelson (69 papers) published 2 papers at the last edition,
• Geoffrey K. Isbister (68 papers) published 8 papers at the last edition, 6 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical Toxicology (based on the number of publications) are:

• Boston Children's Hospital (134 papers) published 7 papers at the last edition the same number as at the previous edition,
• University of California, San Francisco (131 papers) published 11 papers at the last edition, 7 more than at the previous edition,
• New York University (112 papers) published 3 papers at the last edition, 4 less than at the previous edition,
• University of California, San Diego (84 papers) published 4 papers at the last edition, 3 more than at the previous edition,
• University of Pittsburgh (82 papers) published 5 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 11.90% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 20.80% were posted by at least one author from the top 10 institutions publishing in the journal. Another 17.15% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.79% of all publications and 45.26% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Clinical Toxicology

While the field of clinical toxicology is rich with research and academic opportunities, it also opens doors to rewarding careers in various sectors such as healthcare, forensic sciences, pharmaceuticals, environmental safety, academia, and government regulatory bodies. Clinical toxicologists play pivotal roles in diagnosing and managing poisoning cases, drug overdoses, and other instances of contact with harmful substances. They may work in hospitals, poison control centers, drug safety monitoring agencies, research institutions, and even the evolving space of biotech startups.

For example, a career in healthcare as a clinical toxicologist often involves working with a team of healthcare professionals to manage cases of poisoning and overdose. This requires a strong understanding of pharmacology and internal medicine - precisely the subjects that are extensively dealt with in Clinical Toxicology.

In the academic field, clinical toxicologists contribute significantly to the research of anesthesia, toxicity, and other toxic phenomena associated with various substances, their interactions, and effects on the human body. This knowledge is crucial in understanding and managing severe conditions or incidents related to poisoning or drug overdose.

Lastly, for those aspiring to enter this fields, it's crucial to get the proper education and training. There are several excellent degrees and institutions focused on this. For instance, individuals interested in combining nursing with toxicology can look into best nursing schools in Louisiana. Beyond higher education degrees, certifications like Diplomate of the American Board of Toxicology (DABT) are also valuable.